感恩回馈，限时折扣
即日起至2022年10月18日，蛋白产品享5折优惠！最低至300元！
现货产品，无需等待
活动产品涵盖几乎所有肿瘤免疫与新冠研究热门靶点
| 2B4 | 4-1BB | ACE2 | B7-1 | B7-2 | B7-H3 |
| BCMA | CB1 | CD138 | CS1 | CSPG4 | GPRC5D |
| MSLN | OX40 | OX40-L | PD-1 | PD-L1 | PSMA |
| ROR1 | SIRPα | TIGIT | TIM3 | vWF | And more |
快拨打18062749453联系我们吧！
| 缔码重组ECD融合蛋白 | |||
| √ HEK293表达系统，修饰更天然 | √ 无血清培养体系，内毒素更低 | √ 冻干储存，稳定性更高 | √ 优化工艺，批间差异更小 |
| ▼ 高稳定性：SDS-PAGE验证纯度>95%, 37℃ 放置3天蛋白纯度及活性无明显变化 | |||
  Human CCR8 protein (Cat# PME101091)produced from HEK293 cells was tested by SDS-PAGE and Coomassie blue staining (Left), and ELISA binding assay with anti-CCR8 biosimilar antibody (Right, Cat# BME100063), after freshly made and stored in lyophilized format at 37℃ for 24h, 48h and 72h respectively. | |||
| ▼ 高活性：中和抗体互作及配受体结合实验验证蛋白活性 | |||
  Human CD47 protein(Cat# PME100008) was produced from HEK293 cells and tested by ELISA binding assays with Anti-CD47 neutralizing antibody (Left, clone Hu5F9-G4, Cat# BME100001), and its native ligand Human SIRPα protein (Right, Cat# PME100009). | |||
| ▼ 批间差异小：不同批次间纯度及活性无明显差异 | |||
  Similar levels of purity and bioactivity of human CCR8 protein (Cat# PME101091) from different purification lots were detected by SDS-PAGE and Coomassie blue staining (Left) and ELISA binding assay (Right). | |||
活动说明
1.活动时间：2022.04.18-2022.10.18
2.该活动仅限终端使用者
3.该活动仅针对官网规格，订购更大规格请询价
4.该活动不与其他优惠同享
5.本活动最终解释权归缔码生物科技有限公司所有